QuantCapitol. Congressional Trading Intelligence

Updated 2026-11-05 08:10 UTC · Public disclosure record

FIGTICKER

Figma, Inc.

INSUFFICIENT DATA other

Congress has disclosed 4 buys and 2 sells of FIG (Figma, Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.

Activity Congressional Activity

4
Buy
2
Sell
+2
Net
1
Active politicians

Round-trip watch Still on the books

Members who disclosed buying FIG and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.

MemberEntry (last buy)Entry priceNowvs entryStatus
Cleo Fields 2025-10-10 $61.06 $21.65 -64.5% underwater

Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).

Price & congressional trades
Buy Sell

Fundamentals · FY2026 Valuation

Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Technology. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.

P/B
7.7
▲ pricier than Technology (median 6.2)
how it's calculated
P/B = price ÷ book value per share
$21.65 ÷ $2.81 = 7.7
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
EV/EBITDA
-6.96
≈ in line with Technology (median 21.5)
how it's calculated
EV/EBITDA = (market cap + net debt) ÷ EBITDA — net cash lowers EV
($11.4B − $0.4B net cash) ÷ $-1.6B = $10.9B ÷ $-1.6B = -6.96
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.

Legislation Related Legislation

Recent bills in this stock's sector (Technology). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.

BillTitlePolicy areaLatest action
HR 7022 Mystic Alerts Act Science, Technology, Communications 2026-10-22
S 5663 PROOF Act Science, Technology, Communications 2026-09-30
SRES 923 A resolution expressing support for the designation of October 4 through October 10, 2026, as "National 4-H Week". Science, Technology, Communications 2026-09-29
HR 10610 Stop Spam Calls Act Science, Technology, Communications 2026-09-24
HR 10594 Reliable Artificial Intelligence Research Act of 2026 Science, Technology, Communications 2026-09-24

6 trades Recent Congressional Trades

Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.

PoliticianChamberTypeOwnerDateDisclosure lagPrice move
in that
window
AmountScoreSource
Cleo Fields House SELL OTHER ◆ insider convergence · moderate Self · Morgan Stanley - E*TRADE #2 L: US 2025-12-26 0 days 0.0% $1K–$15K
<0.1% of NW
4.9 ↗ filing
Cleo Fields House SELL OTHER ◆ insider convergence · moderate Self · Morgan Stanley - E*TRADE #2 L: US 2025-12-26 0 days 0.0% $15K–$50K
0.1% of NW
17.9 ↗ filing
Cleo Fields House BUY OTHER ◆ insider divergence · moderate Self · Morgan Stanley - E*TRADE #2 L: US 2025-10-10 0 days 0.0% $1K–$15K
<0.1% of NW
7.5 ↗ filing
Cleo Fields House BUY OTHER ◆ insider convergence · strong Self · Morgan Stanley - E*TRADE #2 L: US 2025-09-10 0 days 0.0% $1K–$15K
<0.1% of NW
13.0 ↗ filing
Cleo Fields House BUY OTHER ◆ insider convergence · strong Self · Morgan Stanley - E*TRADE #2 L: US 2025-08-01 3 days -27.4% $15K–$50K
0.1% of NW
69.4 ↗ filing
Cleo Fields House BUY OTHER ◆ insider convergence · strong Self · Morgan Stanley - E*TRADE #2 L: US 2025-08-01 3 days -27.4% $1K–$15K
<0.1% of NW
62.4 ↗ filing

Corporate insiders · SEC Form 4 Insider Activity

What the company's own officers and directors did in FIG — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →

5
Congress trades with insider convergence
1
…with insider divergence
187
Insider open-market trades

Of the congressional trades in FIG, 5 coincided with corporate insiders moving the same way within 60 days, and 1 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.

DateInsiderRoleTypeSizeSource
2026-10-15 Radakovich Lynn Vojvodich Director SELL 10b5-1 $77K ↗ EDGAR
2026-10-15 Radakovich Lynn Vojvodich Director SELL 10b5-1 $381K ↗ EDGAR
2026-10-05 Herb Tyler C-suite SELL 10b5-1 $31K ↗ EDGAR
2026-10-05 Mulligan Brendan Other SELL 10b5-1 $450K ↗ EDGAR
2026-09-03 Herb Tyler C-suite SELL 10b5-1 $37K ↗ EDGAR
2026-09-03 Mulligan Brendan Other SELL 10b5-1 $1.7M ↗ EDGAR
2026-09-03 Mulligan Brendan Other SELL 10b5-1 $1.2M ↗ EDGAR
2026-08-28 Mulligan Brendan Other SELL 10b5-1 $2.4M ↗ EDGAR
2026-08-28 Mulligan Brendan Other SELL 10b5-1 $3.9M ↗ EDGAR
2026-08-28 Mulligan Brendan Other SELL 10b5-1 $3K ↗ EDGAR
2026-08-27 Herb Tyler C-suite SELL 10b5-1 $60K ↗ EDGAR
2026-08-21 Herb Tyler C-suite SELL 10b5-1 $50K ↗ EDGAR
2026-08-10 Index Ventures VI (Jersey) LP Other SELL $317K ↗ EDGAR
2026-08-10 Rimer Daniel H. Director SELL $317K ↗ EDGAR
2026-08-05 Voskanian Shaunt C-suite SELL 10b5-1 $837K ↗ EDGAR
2026-08-04 Herb Tyler C-suite SELL 10b5-1 $18K ↗ EDGAR
2026-08-04 Melwani Praveer C-suite SELL 10b5-1 $74K ↗ EDGAR
2026-08-04 Melwani Praveer C-suite SELL 10b5-1 $339K ↗ EDGAR
2026-08-04 Melwani Praveer C-suite SELL 10b5-1 $652K ↗ EDGAR
2026-08-04 Voskanian Shaunt C-suite SELL 10b5-1 $25K ↗ EDGAR
2026-08-04 Voskanian Shaunt C-suite SELL 10b5-1 $108K ↗ EDGAR
2026-08-04 Voskanian Shaunt C-suite SELL 10b5-1 $208K ↗ EDGAR
2026-08-04 Rasmussen Kris C-suite SELL 10b5-1 $5.0M ↗ EDGAR
2026-08-03 Herb Tyler C-suite SELL 10b5-1 $40K ↗ EDGAR
2026-07-29 Melwani Praveer C-suite SELL 10b5-1 $9.6M ↗ EDGAR

Combined timeline — Congress & insiders

Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.

DateWhoTypeSize
◆ insider 2026-10-15 Radakovich Lynn Vojvodich Director 10b5-1 SELL $77K
◆ insider 2026-10-15 Radakovich Lynn Vojvodich Director 10b5-1 SELL $381K
◆ insider 2026-10-05 Herb Tyler C-suite 10b5-1 SELL $31K
◆ insider 2026-10-05 Mulligan Brendan Other 10b5-1 SELL $450K
◆ insider 2026-09-03 Herb Tyler C-suite 10b5-1 SELL $37K
◆ insider 2026-09-03 Mulligan Brendan Other 10b5-1 SELL $1.7M
◆ insider 2026-09-03 Mulligan Brendan Other 10b5-1 SELL $1.2M
◆ insider 2026-08-28 Mulligan Brendan Other 10b5-1 SELL $2.4M
◆ insider 2026-08-28 Mulligan Brendan Other 10b5-1 SELL $3.9M
◆ insider 2026-08-28 Mulligan Brendan Other 10b5-1 SELL $3K
◆ insider 2026-08-27 Herb Tyler C-suite 10b5-1 SELL $60K
◆ insider 2026-08-21 Herb Tyler C-suite 10b5-1 SELL $50K
◆ insider 2026-08-10 Index Ventures VI (Jersey) LP Other SELL $317K
◆ insider 2026-08-10 Rimer Daniel H. Director SELL $317K
◆ insider 2026-08-05 Voskanian Shaunt C-suite 10b5-1 SELL $837K
◆ insider 2026-08-04 Herb Tyler C-suite 10b5-1 SELL $18K
◆ insider 2026-08-04 Melwani Praveer C-suite 10b5-1 SELL $74K
◆ insider 2026-08-04 Melwani Praveer C-suite 10b5-1 SELL $339K
◆ insider 2026-08-04 Melwani Praveer C-suite 10b5-1 SELL $652K
◆ insider 2026-08-04 Voskanian Shaunt C-suite 10b5-1 SELL $25K
◆ insider 2026-08-04 Voskanian Shaunt C-suite 10b5-1 SELL $108K
◆ insider 2026-08-04 Voskanian Shaunt C-suite 10b5-1 SELL $208K
◆ insider 2026-08-04 Rasmussen Kris C-suite 10b5-1 SELL $5.0M
◆ insider 2026-08-03 Herb Tyler C-suite 10b5-1 SELL $40K

FAQ Common questions

How much has Congress traded FIG?

4 disclosed buys and 2 sells of FIG (Figma, Inc.) appear in official congressional financial disclosures.

Is it legal for members of Congress to trade FIG?

Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.

Where does this data come from?

Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.

About this data. Sourced from official House Clerk and Senate eFD financial disclosures (Senate via a maintained community mirror — see project documentation). Transaction amounts are reported as ranges, not exact figures. Interest scores, consensus labels, and backtested performance are proprietary analytical calculations based on public data and are not investment advice. Backtested performance is a hypothetical simulation, not actual portfolio performance.